MBL-IN-4
MBL-IN-4 (compound 4b) is a MBL inhibitor with the IC50 of 4.81 and 33 μM against IMP-1 and NDM-1[1].
Product Specifications
UNSPSC
12352005
Target
Bacterial; Beta-lactamase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mbl-in-4.html
Smiles
CC1=CC=C(C=C1)OCCCN(C2=CC=C3NC(CCC3=C2)=O)CCC4CCCCC4
Molecular Formula
C27H36N2O2
Molecular Weight
420.59
References & Citations
[1]Kamo T, et al. Development of Inhibitory Compounds for Metallo-beta-lactamase through Computational Design and Crystallographic Analysis. Biochemistry. 2024;63 (10) :1278-1286.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041528-500 1x 500 µL
BTLA (BTLA/1528), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
E-EL-M1084-01 24 Tests
Mouse TRAIL/TNFSF10 (Tumor Necrosis Factor Related Apoptosis Inducing Ligand) ELISA Kit
Sign In for Pricing
View Details